Central Nervous System Depressants has 3 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Azelastine, Azelastine Hydrochloride, Olopatadine Hydrochloride And Mometasone Furoate. Patients taking Central Nervous System Depressants should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 3
- Moderate
- 3
Moderate (3)
- Central Nervous System Depressants + Azelastine— Concurrent use with azelastine may cause reductions in alertness and impairment of central nervous system performance; c…
- Central Nervous System Depressants + Azelastine Hydrochloride— Concurrent use may cause reductions in alertness and impairment of central nervous system performance; should be avoided…
- Central Nervous System Depressants + Olopatadine Hydrochloride And Mometasone Furoate— Concurrent use with CNS depressants should be avoided due to risk of somnolence and impairment of CNS performance.